Menken Trials
Menken Trials sells an AI-powered clinical trial compliance platform combining eTMF, eISF, EDC, and CRA workspace modules, with Menka AI running 500+ automated compliance checks, to pharmaceutical sponsors, CROs, and clinical research sites across Europe.
- Company typePrivate
- Founded2022
- HeadquartersTartu, Estonia
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Menken Trials does
Menken Trials (legal entity Menken OÜ) is a Tartu, Estonia-based software company founded in 2022 that sells an AI-powered clinical trial compliance platform to pharmaceutical sponsors, contract research organizations, and clinical research sites. The company bundles four products into a single environment: an electronic Trial Master File (eTMF), an electronic Investigator Site File (eISF), an electronic Data Capture (EDC) system, and a Clinical Research Associate workspace called Menken Monitor. The eTMF and eISF share a connected architecture so site-level and sponsor-level documents flow automatically with synchronized metadata and permissions, addressing a structural fragmentation problem in the clinical trial documentation stack.
The platform's core technical component is Menka AI, an always-on agent that runs more than 500 automated compliance checks on every uploaded document, log, and milestone, detects missing signatures, expired certificates, version mismatches, and delegation-to-training gaps in real time, and supports plain-language queries over study state. The system is certified to GDPR, SOC 2 Type II, ISO 27001, 21 CFR Part 11, ICH-GCP, CDISC TMF Reference Model v3.3.1, and EMA GCP, and the company claims zero inspection findings across all clients and studies to date.
Menken Trials operates an enterprise sales-led go-to-market with quote-based multi-year subscription contracts, volume and white-label licensing for CROs, and self-serve signup for individual CRAs on the Monitor module. The company is bootstrapped in the traditional sense, with no disclosed institutional venture round; capital has come from the Tenity and DayOne accelerators, an EAS grant of approximately $1.4 million in 2024, and Estonian state R&D funding tied to a 2025 expansion into Switzerland and Germany, layered on top of its Estonian and Latvian customer base that includes Lisata Therapeutics, regenold GmbH, and several regional hospitals.
Menken Trials firmographics
Firmographics- Name
- Menken Trials
- Legal name
- Menken OÜ
- Website
- https://menkentrials.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Menken Trials sells an AI-powered clinical trial compliance platform combining eTMF, eISF, EDC, and CRA workspace modules, with Menka AI running 500+ automated compliance checks, to pharmaceutical sponsors, CROs, and clinical research sites across Europe.
- Ownership category
- akta.pro rank
Menken Trials industry classification
Industry- Product category
- Clinical Trial Compliance Software
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- eTMF & Trial Document Management (HLACAOAF)
- akta.pro secondary industries
- Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG), Clinical Trial Site Operations & Study Coordination (HLAGACAE), Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ)
Keywords
Where Menken Trials is headquartered
LocationHeadquarters
- HQ city
- Tartu
- HQ country
- Estonia
- HQ region
- Europe
Offices1 record
Markets served
Menken Trials business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Platform Subscription: SaaS subscription model for access to eTMF, eISF, EDC, and Monitor modules. Pricing appears enterprise/quote-based with volume and portfolio options available for multi-sponsor and TA-specific use.
- Professional Services: Configuration and setup services included as part of the offering (study design, database and forms built for clients). The company designs the study database and forms for customers as part of the service.
- CRO Licensing: CRO-wide licensing options with white-label capability for CRO logo and colour themes. Volume and portfolio pricing available for TA-specific and multi-sponsor use.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise platform subscription with all modules |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Menken Trials product offering
Product offeringCore offering
Menken Trials provides an AI-powered, integrated clinical trial compliance platform consisting of an eTMF (Electronic Trial Master File), eISF (Electronic Investigator Site File), EDC (Electronic Data Capture), and a CRA workspace called Menken Monitor, all continuously monitored by Menka AI, the company's proprietary always-on compliance agent. The platform replaces periodic, manual document review with 500+ automated real-time checks, plain-language study querying, AI metadata extraction, and connected sponsor-site document flows. It is sold as a SaaS subscription primarily to pharmaceutical sponsors, CROs, and clinical research sites/hospitals to deliver continuous inspection readiness and reduce manual QC work.
Product overview
Menken Trials offers a unified, integrated clinical trial compliance platform consisting of four core modules—eTMF (Electronic Trial Master File) for sponsor-level documentation, eISF (Electronic Investigator Site File) for site-level documentation, EDC (Electronic Data Capture) for data collection, and Menken Monitor for CRA workspace management—all powered by Menka AI, an always-on compliance agent that runs 500+ continuous AI checks across the entire platform. The eTMF and eISF are directly connected within the same platform, enabling real-time synchronization and simultaneous monitoring by Menka AI, eliminating the traditional separation between sponsor and site document management. The platform is designed for inspection readiness throughout the study lifecycle rather than as preparation before inspection, delivering zero inspection findings across every client and study.
Differentiator
Problem solved
Functional benefit
Products and services
- eTMF (Electronic Trial Master File) A purpose-built electronic Trial Master File system for pharmaceutical and biotech sponsors that simplifies document collection, tracking, and quality control with 500+ AI-powered automated compliance checks and a CDISC TMF Reference Model v3.3.1 structure for inspection readiness.
- eISF (Electronic Investigator Site File) A digital site file for investigational sites and hospitals that automates documentation, simplifies compliance, and keeps sponsors informed without burdening sites — featuring fully digital logs, smart workflow automation, automatic regulatory checks, and seamless real-time connectivity to the eTMF.
- EDC (Electronic Data Capture) An electronic data capture system enabling study launch in days with a drag-and-drop form builder, real-time edit checks, full compliance (21 CFR Part 11, ICH-GCP, GDPR) built in, and direct connectivity to eTMF and eISF within the same platform.
- Menken Monitor (CRA Workspace) A digital companion for Clinical Research Associates providing full oversight over trials, sites, and tasks; visit planning and deadline tracking; findings management; and AI-assisted report writing in a single structured workspace; available via self-serve signup at monitor.menkentrials.com with enterprise features available through sales.
- Menka AI An always-on AI compliance agent built into the Menken Trials platform that runs 500+ continuous AI checks on every document, flags compliance issues in real time, answers plain-language queries about study compliance status, and ensures zero inspection findings across all clients and studies.
Quantifiable outcome
- Zero inspection findings related to platform across every client, every study, ever
- +3 more outcomes
Companies that use Menken Trials
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles3 records
Menken Trials technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature6 records
Menken Trials partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Estonian Startup EcosystemminorPart of Estonia's emerging MedTech hub leveraging world-leading digital infrastructure including nationwide electronic health records and secure digital identity systems. Ecosystem characterized by government support and active university involvement in research and commercialisation.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Menken Trials competitors and assessment
Company assessmentBroad incumbents
- Veeva Systems: Veeva is the dominant eTMF/CTMS provider for life sciences, with Veeva Vault eTMF directly competing against Menken Trials' core eTMF module. While Veeva serves large enterprise pharma broadly, it is the most direct point of comparison for the eTMF functionality Menken offers, and serves the same sponsor/CRO buyer.
- Medidata (Dassault Systèmes): Medidata's Rave platform is the leading EDC and eClinical suite, directly comparable to Menken's EDC module and broader clinical trial platform. As part of Dassault Systèmes, Medidata serves the same pharma, biotech, and CRO buyer segments with a much larger portfolio.
- Oracle Clinical One: Oracle Clinical One is a unified clinical trial platform (EDC, RTSM, eTMF) targeting the same large pharma and CRO buyers as Menken. As a broad incumbent from Oracle, it competes on integration with the broader Oracle Health Sciences stack.
- Clario: Clario is a major clinical trial technology and eCOA provider, offering endpoint data solutions that overlap with Menken's EDC and broader trial platform. It serves the same pharma, biotech, and CRO buyer base with a wider portfolio including imaging and cardiac safety.
- Advarra: Advarra provides clinical trial technology (including eRegulatory/ISF solutions via its Longboat acquisition) and research services. It competes with Menken's site-facing eISF and sponsor-facing eTMF in the academic and CRO segments.
- Veeva Vault CTMS: Veeva Vault CTMS is a clinical trial management system that competes with the workflow/monitoring functionality in Menken's Monitor module. Same Veeva parent, same enterprise buyer, and same regulated workflow focus.
Direct peers
- Castor: Castor is an eClinical platform offering EDC, ePRO, and eConsent directly competing with Menken's EDC and broader trial platform. Both target academic, biotech, and CRO customers with self-serve and enterprise tiers, and both emphasize speed of study setup.
- Florence (now part of Vial): Florence provides an eISF and eRegulatory platform for clinical research sites, directly comparable to Menken's eISF module. Both target investigator sites and sponsors with digital site file solutions and compete for the same research-site buyer.
- RealTime Software Solutions: RealTime provides eRegulatory (eISF) and CTMS solutions specifically for clinical research sites, directly comparable to Menken's eISF. Both target site-level buyers (hospitals, investigator sites) with workflow automation for regulatory documents.
Emerging players
- Trial Library: Trial Library is an emerging clinical trial operations and feasibility platform. While it focuses more on trial sponsors and site selection, it represents a new generation of AI-driven clinical trial tools targeting similar buyer segments to Menken.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Menken Trials social profiles
Digital presenceMenken Trials compliance and trust
Trust signalCompliance7 records
Menken Trials financial estimates
Financial estimateRevenue estimate
Valuation estimate
Menken Trials leadership team
Management profileNumber of profiles
Profiles2 records
Menken Trials funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Menken Trials M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Menken Trials
What does Menken Trials do?
Menken Trials provides an AI-powered, integrated clinical trial compliance platform consisting of an eTMF (Electronic Trial Master File), eISF (Electronic Investigator Site File), EDC (Electronic Data Capture), and a CRA workspace called Menken Monitor, all continuously monitored by Menka AI, the company's proprietary always-on compliance agent. The platform replaces periodic, manual document review with 500+ automated real-time checks, plain-language study querying, AI metadata extraction, and connected sponsor-site document flows. It is sold as a SaaS subscription primarily to pharmaceutical sponsors, CROs, and clinical research sites/hospitals to deliver continuous inspection readiness and reduce manual QC work.
Is Menken Trials a public or private company?
Menken Trials is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Menken Trials founded?
Menken Trials was founded in 2022. It employs 1 to 10 people.
Where is Menken Trials based?
Menken Trials is headquartered in Tartu, Estonia, in the Europe region.
How does Menken Trials make money?
Three revenue lines are on record. Platform Subscription is the primary driver. The others are professional Services and CRO Licensing.
Who are Menken Trials's main competitors?
Broad incumbents on record are Veeva Systems, Medidata (Dassault Systèmes), Oracle Clinical One, Clario, Advarra and Veeva Vault CTMS. Direct peers are Castor, Florence (now part of Vial) and RealTime Software Solutions. Trial Library is listed as an emerging player.
Does Menken Trials have an API?
No public API is recorded for Menken Trials.
What industry is Menken Trials in?
Menken Trials's product category is Clinical Trial Compliance Software. Its primary akta.pro industry code is HLACAOAF, eTMF & Trial Document Management, with a secondary code of HLAGACAG, Clinical Trial Monitoring Support (On-site/Remote). Its NAICS code is 5417 and its SIC code is 8071.